The Europe generic drug market was valued at USD 61.1 billion in 2023 and is projected to reach USD 110.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2032. Key factors fueling this growth include the rising prevalence of chronic diseases like diabetes and cardiovascular conditions, innovations in drug formulations such as fixed-dose combinatio... http://www.imarcgroup.com/europe-generic-drug-market